Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip Scheinberg

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Immunohorizons|June 3, 2025
Efficacy and safety of acalabrutinib with best supportive care versus best supportive care in patients with COVID-19 requiring hospitalizationPhillip Scheinberg, Matt R Khoshnevis, Philip A Robinson, et al.
European Journal of Immunology|October 20, 2007
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populationsNatalie E R Beveridge, David A Price, Joseph P Casazza, et al.
Annals of Hematology|August 18, 2017
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemiaElias H Atta, Carlos B L Lima, Danielle S P Dias, et al.
Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
International Journal of Molecular Sciences|June 12, 2026
Unraveling the Role of Zonulin in Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter StudyAlexandre Soares Ferreira Junior, Nathalia Linares Silva, Danielle Amanda Niz Alvarez, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Bone Marrow Transplantation|July 6, 2021
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life studyPierre-Edouard Debureaux, Austin G Kulasekararaj, Fabiana Cacace, et al.
Annals of Hematology|July 7, 2018
Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective studyDiego V Clé, Elias H Atta, Danielle S P Dias, et al.
American Journal of Hematology|June 26, 2024
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Diego Villa Clé, Jin Seok Kim, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Immunohorizons|June 3, 2025
Efficacy and safety of acalabrutinib with best supportive care versus best supportive care in patients with COVID-19 requiring hospitalizationPhillip Scheinberg, Matt R Khoshnevis, Philip A Robinson, et al.
European Journal of Immunology|October 20, 2007
Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populationsNatalie E R Beveridge, David A Price, Joseph P Casazza, et al.
Annals of Hematology|August 18, 2017
Predictors of early mortality after rabbit antithymocyte globulin as first-line treatment in severe aplastic anemiaElias H Atta, Carlos B L Lima, Danielle S P Dias, et al.
Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
International Journal of Molecular Sciences|June 12, 2026
Unraveling the Role of Zonulin in Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter StudyAlexandre Soares Ferreira Junior, Nathalia Linares Silva, Danielle Amanda Niz Alvarez, et al.
The Lancet. Haematology|January 15, 2016
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 studyBogdan Dumitriu, Sawa Ito, Xingmin Feng, et al.
Bone Marrow Transplantation|July 6, 2021
Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life studyPierre-Edouard Debureaux, Austin G Kulasekararaj, Fabiana Cacace, et al.
Annals of Hematology|July 7, 2018
Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective studyDiego V Clé, Elias H Atta, Danielle S P Dias, et al.
American Journal of Hematology|June 26, 2024
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuriaPhillip Scheinberg, Diego Villa Clé, Jin Seok Kim, et al.
Pageof 13